Adaptation of the urticaria patient daily diary for caregiver completion in pediatric chronic spontaneous urticaria

<b>Background:</b> The Urticaria Patient Daily Diary (UPDD) assesses patient-reported symptoms (itch, hives, angioedema) and impacts in adults and adolescents with chronic spontaneous urticaria (CSU). <b>Objective:</b> The objective was to adapt the UPDD for caregiver completion for patients ages 2-11 years. <b>Methods:</b> To inform modification of the UPDD, two iterative rounds of hybrid concept-elicitation/cognitive-debriefing interviews were conducted with clinical experts and caregivers of children with CSU recruited <i>via</i> patient organizations in the United States and Canada. After concept elicitation, the participants reviewed a draft UPDD-Caregiver Version with initial modifications for caregiver completion. Data were analyzed by using thematic analysis. <b>Results:</b> Four clinicians and 12 caregivers were interviewed (round 1:4 clinicians, 5 caregivers; round 2:7 caregivers). Key symptoms reported by the caregivers were itch (n = 12), hives (n = 12), and swelling and/or angioedema (n = 7). All four clinicians confirmed itch and hives to be key symptoms in children ages 2-11 years with CSU, with associated angioedema for some. Scratching was confirmed as the key observable sign of itch. Caregiver-reported impacts included waking in the night (n = 10); difficulty getting to sleep (n = 8); and daily life impacts, including activities at school (n = 10), play (n = 8), with family and/or friends (n = 4), and sports (n = 3). After round 1, minor revisions were made to enhance comprehension of the UPDD-Caregiver Version, and an overall symptom severity item was added. Relevance, acceptability, and comprehension of the final measure were confirmed by round 2 participants; no further changes were required. <b>Conclusion:</b> The UPDD-Caregiver Version is a relevant and acceptable measure for caregiver completion to assess symptoms and impacts of CSU in children ages 2-11 years.

Authors

Institutions

Publication Details

Journal
Allergy and Asthma Proceedings
Published
2025-10-29
DOI
https://doi.org/10.2500/aap.2025.46.250062
Primary Topic
Urticaria and Related Conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adaptation of the urticaria patient daily diary for caregiver completion in pediatric chronic spontaneous urticaria

Michel Erlewyn‐Lajeunesse, Donna D. Gardner, Christel Naujoks, Weily Soong et al.
Allergy and Asthma Proceedings
Urticaria and Related Conditions
article

Adaptation of the urticaria patient daily diary for caregiver completion in pediatric chronic spontaneous urticaria

Michel Erlewyn‐Lajeunesse, Donna D. Gardner, Christel Naujoks, Weily Soong, Karsten Weller, Lauri‐Ann Van der Poel, Diane Whalley, Elaine Dery, M.M. Balp
article en

Abstract

<b>Background:</b> The Urticaria Patient Daily Diary (UPDD) assesses patient-reported symptoms (itch, hives, angioedema) and impacts in adults and adolescents with chronic spontaneous urticaria (CSU). <b>Objective:</b> The objective was to adapt the UPDD for caregiver completion for patients ages 2-11 years. <b>Methods:</b> To inform modification of the UPDD, two iterative rounds of hybrid concept-elicitation/cognitive-debriefing interviews were conducted with clinical experts and caregivers of children with CSU recruited <i>via</i> patient organizations in the United States and Canada. After concept elicitation, the participants reviewed a draft UPDD-Caregiver Version with initial modifications for caregiver completion. Data were analyzed by using thematic analysis. <b>Results:</b> Four clinicians and 12 caregivers were interviewed (round 1:4 clinicians, 5 caregivers; round 2:7 caregivers). Key symptoms reported by the caregivers were itch (n = 12), hives (n = 12), and swelling and/or angioedema (n = 7). All four clinicians confirmed itch and hives to be key symptoms in children ages 2-11 years with CSU, with associated angioedema for some. Scratching was confirmed as the key observable sign of itch. Caregiver-reported impacts included waking in the night (n = 10); difficulty getting to sleep (n = 8); and daily life impacts, including activities at school (n = 10), play (n = 8), with family and/or friends (n = 4), and sports (n = 3). After round 1, minor revisions were made to enhance comprehension of the UPDD-Caregiver Version, and an overall symptom severity item was added. Relevance, acceptability, and comprehension of the final measure were confirmed by round 2 participants; no further changes were required. <b>Conclusion:</b> The UPDD-Caregiver Version is a relevant and acceptable measure for caregiver completion to assess symptoms and impacts of CSU in children ages 2-11 years.

Allergy and Asthma ProceedingsVol. 46(6)
Novartis (Switzerland) (CH), Virginia College (US), Humboldt-Universität zu Berlin (DE), Allergy, Asthma and Clinical Research Center (US), Southampton Children's Hospital (GB), RTI Health Solutions (US), Kensington Health (CA), Canadian Anthropology Society (CA), Freie Universität Berlin (DE), Charité - Universitätsmedizin Berlin (DE)
Openalex Percentile: Top 55%
Urticaria and Related Conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.